Annexon Biosciences
Develops therapies for complement-mediated neuroinflammatory and autoimmune diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2011
- Employees
- 118
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ANNX
- Subsidiaries
- Annexon Biosciences Australia Pty Ltd
Open positions
2 jobs
4 views 3 weeks ago
Vice President, Medical Affairs-Neuroimmunology
Open 131d North AmericaC-level
United States
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases…
GCP Proof of Concept
4 views 5 months ago
Associate Director, Clinical Trial Management
Open 131d North AmericaContractC-level
United States
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases…
GCP Proof of Concept
179K – 200K $